Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis (2007)
Iida, Katsuyuki, Itoh, Ken, Maher, Jonathan M., Kumagai, Yoshito, Oyasu, Ryoichi, Mori, Yukio, ...
Nuclear factor-erythroid 2 (NF-E2)-related factor 2 (Nrf2), a transcription factor that regulates inducible expression of detoxifying enzymes, is critical in preventing...
Shimazui, Toru, Kawai, Koji, Miyanaga, Naoto, Kojima, Takahiro, Sekido, Noritoshi, Hinotsu, Shiro, ...
Background We previously reported that weekly treatment with docetaxel alone is useful for and well tolerated by patients with hormone-refractory prostate cancer (HRPC). Here, we compare it with the...
Miyanaga, Naoto, Akaza, Hideyuki, Hinotsu, Shiro, Joraku, Akira, Oikawa, Takehiro, Sekido, Noritoshi, ...
Objective The present study was undertaken to identify the patients suitable for bladder preservation by analysis of our data. Methods The subjects of this study were all 72 patients with T2–3N0M0...
Miyagawa, Tomoaki, Shimazui, Toru, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...
Background We retrospectively evaluated the effects of tumor size and microvascular tumor invasion on the clinical outcomes of patients who had undergone radical nephrectomy for renal cell carcinoma...
Kawai, Koji, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Hattori, Kazunori, Miyanaga, Naoto, ...
Background Incidence of testicular cancer is low in Japan. Recent investigations showed that the outcome of metastatic testicular cancer is associated with the experience of the treatment...
Kawai, Koji, Ando, Satoshi, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...
Background: Combination of bleomycin, etoposide and cisplatin (BEP) remains the standard chemotherapy for testicular cancer. Since the development of BEP in the 1980s, there has been a considerable...
Takaoka, Ei-Ichiro, Kawai, Koji, Ando, Satoshi, Shimazui, Toru, Akaza, Hideyuki
A 54-year-old man received combination chemotherapy with nedaplatin and irinotecan as salvage chemotherapy for refractory non-seminomatous testicular cancer. The patient developed abdominal pain and...
Takaoka, Ei-Ichiro, Kawai, Koji, Ando, Satoshi, Shimazui, Toru, Akaza, Hideyuki
A 54-year-old man received combination chemotherapy with nedaplatin and irinotecan as salvage chemotherapy for refractory non-seminomatous testicular cancer. The patient developed abdominal pain and...
Kawai, Koji, Ando, Satoshi, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...
Background: Combination of bleomycin, etoposide and cisplatin (BEP) remains the standard chemotherapy for testicular cancer. Since the development of BEP in the 1980s, there has been a considerable...
Kawai, Koji, Takaoka, Ei-Ichiro, Naoi, Makito, Mori, Kensaku, Minami, Manabu, Shimazui, Toru, ...
A 26-year-old man was referred to our hospital for treatment of metastatic testicular cancer. The pathological diagnosis was choriocarcinoma with seminoma. Sequential computerized tomography...
Kawai, Koji, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Hattori, Kazunori, Miyanaga, Naoto, ...
Background: Incidence of testicular cancer is low in Japan. Recent investigations showed that the outcome of metastatic testicular cancer is associated with the experience of the treatment...
Kojima, Takahiro, Shimazui, Toru, Onozawa, Mizuki, Tsukamoto, Sadamu, Hinotsu, Shiro, Miyanaga, Naoto, ...
Objective: Although treatment of hormone-refractory prostate cancer (HRPC) is difficult, a single-agent weekly dose of docetaxel has been reported as a promising regimen for patients with HRPC. The...
Miyazaki, Jun, Kawai, Koji, Hayashi, Hitoshi, Onozawa, Mizuki, Tsukamoto, Sadamu, Miyanaga, Naoto, ...
Background: Combination chemotherapy of methotrexate, actinomycin D and cisplatin (MAP) is reported to be effective against gestational choriocarcinoma. Methods: Eight patients with metastatic...
Kawai, Koji, Miyazaki, Jun, Tsukamoto, Sadamu, Hinotsu, Shiro, Hattori, Kazunori, Shimazui, Toru, ...
Background: Paclitaxel, ifosfamide and cisplatin (TIP) has been tested with successful results on metastatic testicular cancer in Western countries. Because paclitaxel, the key drug of this regimen,...
Survival of Patients with Tumors of the Renal Pelvis and Ureter: A Retrospective Study (1985)
SHIMAZUI, TORU, UCHIDA, KATSUNORI, KONDO, FUKUJI, TAKESHIMA, HITOSHI, ISHIKAWA, HIROMICHI, KANO, SHORI, ...
A review of 27 patients with renal pelvic tumors and ureteral tumors admitted to the Tsukuba University Hospital was performed retrospectively. Nineteen cases of renal pelvic tumors and eleven cases...
UCHIDA, KATSUNORI, SHIMAZUI, TORU, NEMOTO, RYOSUKE, KANO, SHORI, KOISO, KENKICHI
The clinical aspects of 64 patients with superficial bladder cancer (Ta, T1, T2 according to the TNM classification, International Union against Cancer or Stage O, A, Bl according to Marshall)...